These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21333101)

  • 21. Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA.
    Leung ET; Ho PL; Yuen KY; Woo WL; Lam TH; Kao RY; Seto WH; Yam WC
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1075-8. PubMed ID: 16495272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic and genotypic analysis of multidrug-resistant tuberculosis in Ethiopia.
    Agonafir M; Lemma E; Wolde-Meskel D; Goshu S; Santhanam A; Girmachew F; Demissie D; Getahun M; Gebeyehu M; van Soolingen D
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1259-65. PubMed ID: 20843416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concomitant increases in spectrum and level of drug resistance in Mycobacterium tuberculosis isolates.
    Sun Z; Zhang J; Song H; Zhang X; Li Y; Tian M; Liu Y; Zhao Y; Li C
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1436-41, i. PubMed ID: 20937184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular analysis of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India.
    Nusrath Unissa A; Selvakumar N; Narayanan S; Narayanan PR
    Int J Antimicrob Agents; 2008 Jan; 31(1):71-5. PubMed ID: 18006278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidrug- and extensively drug-resistant tuberculosis in Africa and South America: epidemiology, diagnosis and management in adults and children.
    Schaaf HS; Moll AP; Dheda K
    Clin Chest Med; 2009 Dec; 30(4):667-83, vii-viii. PubMed ID: 19925960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extensively drug-resistant (XDR) tuberculosis: an old and new threat.
    Fattorini L; Migliori GB; Cassone A
    Ann Ist Super Sanita; 2007; 43(4):317-9. PubMed ID: 18209265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of INH-resistant Mycobacterium tuberculosis isolates by PCR-RFLP and multiplex-PCR in North India.
    Mathuria JP; Nath G; Samaria JK; Anupurba S
    Infect Genet Evol; 2009 Dec; 9(6):1352-5. PubMed ID: 19786122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystallographic and pre-steady-state kinetics studies on binding of NADH to wild-type and isoniazid-resistant enoyl-ACP(CoA) reductase enzymes from Mycobacterium tuberculosis.
    Oliveira JS; Pereira JH; Canduri F; Rodrigues NC; de Souza ON; de Azevedo WF; Basso LA; Santos DS
    J Mol Biol; 2006 Jun; 359(3):646-66. PubMed ID: 16647717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extensively drug-resistant tuberculosis: "there must be some kind of way out of here".
    Cegielski JP
    Clin Infect Dis; 2010 May; 50 Suppl 3():S195-200. PubMed ID: 20397948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular typing of drug-susceptible and -resistant Mycobacterium tuberculosis in Johannesburg, South Africa.
    Kamudumuli PS; Beylis N; Blann L; Duse A
    Int J Tuberc Lung Dis; 2015 Jul; 19(7):834-40. PubMed ID: 26056111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
    Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
    Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
    [No Abstract]   [Full Text] [Related]  

  • 32. Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation.
    Nikolayevsky V; Brown T; Balabanova Y; Ruddy M; Fedorin I; Drobniewski F
    J Clin Microbiol; 2004 Oct; 42(10):4498-502. PubMed ID: 15472300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. State of the Art series on drug-resistant tuberculosis: it's time to protect fluoroquinolones.
    Chiang CY
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1319. PubMed ID: 19861001
    [No Abstract]   [Full Text] [Related]  

  • 34. Survival in XDR TB: shifting the curve and shifting the paradigm.
    Martinson NA; Chaisson RE
    J Acquir Immune Defic Syndr; 2011 Jun; 57(2):89-91. PubMed ID: 21522018
    [No Abstract]   [Full Text] [Related]  

  • 35. [Molecular-genetic characteristics of Mycobacterium tuberculosis strains isolated in southern region of Ukraine].
    Nikolaevskiĭ VV; Drobniewski FA; Bazhora IuI
    Tsitol Genet; 2004; 38(4):23-8. PubMed ID: 15715161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tuberculosis. Few mutations divide some drug-resistant TB strains.
    Koenig R
    Science; 2007 Nov; 318(5852):901-2. PubMed ID: 17991835
    [No Abstract]   [Full Text] [Related]  

  • 37. Molecular characterisation of isoniazid-resistant Mycobacterium tuberculosis isolated from new cases in Lagunes region (Côte d'Ivoire).
    N'Guessan KR; Dosso M; Ekaza E; Kouakou J; Jarlier V
    Int J Antimicrob Agents; 2008 May; 31(5):498-500. PubMed ID: 18313272
    [No Abstract]   [Full Text] [Related]  

  • 38. Rolling circle amplification and multiplex allele-specific PCR for rapid detection of katG and inhA gene mutations in Mycobacterium tuberculosis.
    Cai L; Kong F; Jelfs P; Gilbert GL; Sintchenko V
    Int J Med Microbiol; 2009 Dec; 299(8):574-81. PubMed ID: 19604720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of drug resistance in Mycobacterium tuberculosis.
    Zhang Y; Yew WW
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1320-30. PubMed ID: 19861002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Totally drug resistant tuberculosis--a fact or myth?
    Behera D
    Indian J Tuberc; 2012 Oct; 59(4):190-3. PubMed ID: 23342538
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.